Literature DB >> 9455793

Vitamin A and cancer prevention I: observations in workers previously exposed to asbestos at Wittenoom, Western Australia.

A W Musk1, N H de Klerk, G L Ambrosini, J L Eccles, J Hansen, N J Olsen, V L Watts, H G Lund, S C Pang, J Beilby, M S Hobbs.   

Abstract

Our aim was to describe a vitamin A-based cancer prevention program for former asbestos workers and to check for possible harmful effects by comparing rates of disease and death in study subjects with subjects who chose not to join. All subjects had been occupationally exposed to crocidolite at Wittenoom Gorge between 1943 and 1966; 1,677 subjects indicated interest in the program and 1,203 joined between June 1990 and May 1995. Comparison subjects consisted of 996 former workers known to be alive in Western Australia in 1990 who did not join the program. Program subjects were provided with annual supplies of vitamin A (either synthetic beta-carotene or retinol), help in quitting smoking and dietary advice. The comparison group received only mail contact. Both groups were followed up to December 1994 for vital status and cancer information, and rates of cancer and death from various causes were compared. Mortality in both groups was higher than expected (standardised mortality ratio 1.23 in program subjects and 1.67 in comparison subjects). After adjustment for age, smoking and asbestos exposure, the relative rates in participants compared with non-participants was below I for all examined cancers and causes of death. For mesothelioma and lung cancer, group differences increased with time from entry, whereas other differences dissipated with time. No significant side effects were reported. In conclusion, program participants had significantly lower mortality than non-participants, but the rates of the 2 groups converged with time.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9455793     DOI: 10.1002/(sici)1097-0215(19980130)75:3<355::aid-ijc5>3.0.co;2-1

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Effects of asbestos and smoking on the levels and rates of change of lung function in a crocidolite exposed cohort in Western Australia.

Authors:  H S Alfonso; L Fritschi; N H de Klerk; N Olsen; J Sleith; A W Musk
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

2.  The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone.

Authors:  A Reid; N de Klerk; G L Ambrosini; N Olsen; S C Pang; G Berry; A W Musk
Journal:  Occup Environ Med       Date:  2005-12       Impact factor: 4.402

3.  The mental health of asbestos-exposed subjects with pleural abnormalities.

Authors:  Peter Franklin; Monique Robinson; Patrick Abaogye-Sarfo; Latha Samuel; Nola Olsen; Rob Mina; A W Musk; Alison Reid
Journal:  Int Arch Occup Environ Health       Date:  2014-07-24       Impact factor: 3.015

4.  No dose-dependent increase in fracture risk after long-term exposure to high doses of retinol or beta-carotene.

Authors:  G L Ambrosini; A P Bremner; A Reid; D Mackerras; H Alfonso; N J Olsen; A W Musk; N H de Klerk
Journal:  Osteoporos Int       Date:  2012-09-18       Impact factor: 4.507

5.  Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia.

Authors:  G Berry; N H de Klerk; A Reid; G L Ambrosini; L Fritschi; N J Olsen; E Merler; A W Musk
Journal:  Occup Environ Med       Date:  2004-04       Impact factor: 4.402

6.  Plasma retinol, carotene and vitamin E concentrations and lung function in a crocidolite-exposed cohort from Wittenoom, Western Australia: a cohort study.

Authors:  Helman S Alfonso; Lin Fritschi; Nicholas H de Klerk; Gina Ambrosini; John Beilby; Nola Olsen; A William Musk
Journal:  Nutr J       Date:  2005-05-11       Impact factor: 3.271

7.  p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression.

Authors:  J Creaney; B M McLaren; S Stevenson; A W Musk; N de Klerk; B W Robinson; R A Lake
Journal:  Br J Cancer       Date:  2001-01-05       Impact factor: 7.640

8.  Asbestos, Pleural Plaques, and Lung Cancer: Untangling the Relationships.

Authors:  Philip Harber
Journal:  Am J Respir Crit Care Med       Date:  2020-01-01       Impact factor: 21.405

9.  Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans.

Authors:  Cleo Robinson; Helman Alfonso; Samantha Woo; Amy Walsh; Nola Olsen; Arthur W Musk; Bruce W S Robinson; Anna K Nowak; Richard A Lake
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

10.  ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.

Authors:  D James Morré; Brandon Hostetler; David J Taggart; Dorothy M Morré; A W Musk; Bruce W S Robinson; Jenette Creaney
Journal:  Clin Proteomics       Date:  2016-01-22       Impact factor: 3.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.